Third-year medical student Ben Peipert co-founded Second Opinions, a student-run pro-bono consulting group, and brings his consulting skills to his research on quality of life in endocrine disorders.
Treating mild hypothyroidism during pregnancy does not lead to improved cognitive functioning in children through five years of age, according to a recent study in the New England Journal of Medicine.
Testosterone treatment in older men reduced anemia but did not improve cognitive function, and was associated with a significant increase in arterial plaque, according to Northwestern Medicine clinical trials.
A JAMA study has found that hemoglobin A1C measurements — a biomarker frequently used to diagnose diabetes — may be less accurate in African-Americans with sickle cell trait.
Joseph Bass, MD, PhD, chief of Endocrinology, Metabolism and Molecular Medicine, focuses his research on illuminating how the body’s clocks regulate feeding behavior and glucose metabolism, and identifies how disruptions in that overarching circadian system play a role in metabolic disease.
Northwestern Medicine scientists have discovered circadian clocks in muscle tissue that control the muscle’s metabolic response and energy efficiency depending on the time of day.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
The latest government guidelines for diabetes screening missed 55 percent of high-risk individuals with prediabetes or diabetes, a new Northwestern Medicine study found.
Northwestern Medicine physicians participated in a clinical trial to investigate the safety and efficacy of a drug for weight management in overweight or obese adults with type 2 diabetes.